Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticlePERSPECTIVES IN PHARMACOLOGY

The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling

Stuart Maudsley, Bronwen Martin and Louis M. Luttrell
Journal of Pharmacology and Experimental Therapeutics August 2005, 314 (2) 485-494; DOI: https://doi.org/10.1124/jpet.105.083121
Stuart Maudsley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwen Martin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis M. Luttrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The modulation of transmembrane signaling by G protein-coupled receptors (GPCRs) constitutes the single most important therapeutic target in medicine. Drugs acting on GPCRs have traditionally been classified as agonists, partial agonists, or antagonists based on a two-state model of receptor function embodied in the ternary complex model. Over the past decade, however, many lines of investigation have shown that GPCR signaling exhibits greater diversity and “texture” than previously appreciated. Signal diversity arises from numerous factors, among which are the ability of receptors to adopt multiple “active” states with different effector-coupling profiles; the formation of receptor dimers that exhibit unique pharmacology, signaling, and trafficking; the dissociation of receptor “activation” from desensitization and internalization; and the discovery that non-G protein effectors mediate some aspects of GPCR signaling. At the same time, clustering of GPCRs with their downstream effectors in membrane microdomains and interactions between receptors and a plethora of multidomain scaffolding proteins and accessory/chaperone molecules confer signal preorganization, efficiency, and specificity. In this context, the concept of agonist-selective trafficking of receptor signaling, which recognizes that a bound ligand may select between a menu of active receptor conformations and induce only a subset of the possible response profile, presents the opportunity to develop drugs that change the quality as well as the quantity of efficacy. As a more comprehensive understanding of the complexity of GPCR signaling is developed, the rational design of ligands possessing increased specific efficacy and attenuated side effects may become the standard mode of drug development.

Footnotes

  • This research was supported by National Institutes of Health Grants DK55524, DK58283, and DK64353 (L.M.L.).

  • doi:10.1124/jpet.105.083121.

  • ABBREVIATIONS: GPCR, G protein-coupled receptor; GEF, guanine nucleotide exchange factor; 5-HT, 5-hydroxytryptamine; NK, neurokinin; CCK, cholecystokinin; GnRH, gonadotropin-releasing hormone; ICI-118-551, (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)-amino]-2-butanol hydrochloride; Ang, angiotensin; MAP, mitogen-activated protein; ERK1/2, extracellular signal-regulated kinases 1 and 2; RAMP, receptor activity modifying protein; RCP, receptor component protein; CRLR, calcitonin receptor-like receptor; GRK, G protein-coupled receptor kinase; mGluR, metabotropic glutamate receptor; PDZ, postsynaptic density protein of 95 kDa/disc-large/zona occludens-1; EGF, epidermal growth factor; HIV, human immunodeficiency virus; Ant135-25, Ac-d-Nal(2)-d-4-ClPhe-d-Pal-Ser-1-MePal-d-IsopropylLys-Leu-IsopropylLys-Pro-d-AlaNH2.

    • Received January 22, 2005.
    • Accepted March 31, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

Log in using your username and password

Forgot your user name or password?

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 372 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 372, Issue 1
1 Jan 2020
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
Research ArticlePERSPECTIVES IN PHARMACOLOGY

The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling

Stuart Maudsley, Bronwen Martin and Louis M. Luttrell
Journal of Pharmacology and Experimental Therapeutics August 1, 2005, 314 (2) 485-494; DOI: https://doi.org/10.1124/jpet.105.083121

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticlePERSPECTIVES IN PHARMACOLOGY

The Origins of Diversity and Specificity in G Protein-Coupled Receptor Signaling

Stuart Maudsley, Bronwen Martin and Louis M. Luttrell
Journal of Pharmacology and Experimental Therapeutics August 1, 2005, 314 (2) 485-494; DOI: https://doi.org/10.1124/jpet.105.083121
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • The Evolution of Receptor Theory
    • The Origins of GPCR Signaling Diversity
    • The Origins of Signaling Specificity
    • Therapeutic Implications
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Acute and Delayed Clinical Manifestations of OP Toxicity
  • Miltefosine as Mediator of the Immune Response
  • Histamine Receptor Knockout Mice
Show more Perspectives in Pharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics